Intellinetics Reports Second Quarter and Six-Month 2026 Results

INTELLINETICS, INC. (INLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Intellinetics Reports Second Quarter and Six-Month 2026 Results COLUMBUS, OH – August 12, 2026 – Intellinetics, Inc. ( NYSE American: INLX ), a digital transformation solutions provider, announced financial results for the three and six months ended June 30, 2026. 20

Original reporting
Published Aug 12, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INLX
Bearish
medium confidence
Mentioned
$INLX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INLXBearishMed
01

Why it matters

The key tradable items are the swing to larger net loss and Adjusted EBITDA loss, margin compression tied to project mix, and management’s reiterated expectation of double-digit YoY SaaS growth for fiscal 2026.

02

Market read

SaaS growth is modestly positive, but profitability worsened materially, making the report a near-term sentiment driver for INLX.

03

What to watch

Professional services and software maintenance declines drove revenue and gross margin deterioration; traders may watch whether management’s internal backlog/pipeline improvement translates into future reported bookings and cash flow.

Relevance 7/10Novelty 7/10Timing: after-hours filing of Q2 and six-month 2026 results (Aug 12, 2026)

Background

This is an SEC Form 8-K with Exhibit 99.1 covering Intellinetics’ Q2 and six-month 2026 financial results and management commentary on scaling SaaS and reducing variability.

Company-level read

Ticker impact

$INLXBearishMedium confidence
Context

Intellinetics reported Q2 2026 revenue of $3.95M, a net loss of $1.09M, and an Adjusted EBITDA loss of $371k, with SaaS up 4.2% YoY.

Expected impact

Likely negative near-term bias as losses and Adjusted EBITDA deterioration outweigh modest SaaS growth, unless investors focus on the stated second-half execution shift.

Evidence & confidence

The filing discloses directionally weaker total revenue and margins, larger operating losses, and a swing to Adjusted EBITDA loss, while only one growth line item (SaaS) offsets part of the deterioration.

Market effects

Signals continued margin pressure for small-cap digital transformation and document automation providers, even when recurring SaaS grows.

Limited, company-specific impact likely confined to US small-cap software/services sentiment.

Low, no cross-border deal, regulation, or macro linkage disclosed.

Counterpoint

Investors may underweight the loss swing if they believe the company’s operating discipline and second-half execution plan can convert SaaS momentum into improved profitability.

Key entities

  • Intellinetics, Inc.

    NYSE American-listed digital transformation solutions provider reporting Q2 and six-month 2026 results.

  • Alison Forsythe

    President and CEO who discussed scaling discipline and second-half priorities, including accelerating SaaS growth.

Related articles

$NOKMed

LightCounting:: November 2026 Nokia SReXperts

Nokia hosted its SReXperts/Wavelengths conference in November 2026, focusing on AI's impact on connectivity and its solutions for customers. The company reported strong Q3 2026 earnings, with AI & Cloud sales doubling year-over-year and $1.7 billion in new orders. Nokia expects 25-30% growth in its Optical and IP Networks businesses in 2027. The company aims to help telecom operators adapt to AI-driven changes and capitalize on new opportunities.

$IBRXLow

IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites

ImmunityBio (IBRX) reported a 53% increase in Q3 net product revenue to $48.7M, with 92% growth for the first nine months. The company is testing its drug Anktiva for sepsis and aims to expand FDA approval for bladder cancer. NantWorks, led by Patrick Soon-Shiong, plans a blockchain-based exchange for tokenized securities. IBRX stock has risen 195% over the past year, with bullish retail sentiment on Stocktwits.

$CSCOHighAI 8/10

What Cisco Systems (CSCO) Said on Its Q1 Earnings Call

Cisco Systems reported Q1 earnings, with total product orders up 21% YoY. Networking orders rose 28%, marking nine straight quarters of double-digit growth. Revenue increased 43% in networking, led by AI infrastructure. Adjusted gross margin fell to 65.6%. Cisco forecasts Q2 revenue of $18B-$18.2B and adjusted earnings of $1.34-$1.36 per share.